Pericardial effusion in patients treated with sotatercept

Robyn Kalda
Oct 2, 2025
1 min read

Because a drug trial for another drug similar to sotatercept was stopped when it was found to be associated with pericardial effusion (fluid around the heart), researchers looked back to see whether five of their sotatercept patients also experienced pericardial effusion. Four of them did have worsening pericardial effusions. Researchers could not tell whether it was due to sotatercept or other confounding factors, but they recommend exploring further.

Read the Pulmonary Circulation article

Recent Posts

Biomarkers identified for high-altitude PH

This study looked at which proteins and metabolic biomarkers might be associated with the development of high-altitude pulmonary hypertension (PH). Looking at data from China, from rat tissues, and fr

Smoking delays PAH diagnosis, but not CTEPH

Researchers looked at whether cigarette smoking affected the diagnosis and disease progression of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension

Environmental triggers may contribute to heritable PAH

This study tried to identify new environmental triggers or genetic causes in heritable pulmonary arterial hypertension. They found several potential genes for further exploration, but they also found

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.